HomeNATCOPHARM • NSE
add
Natco Pharma Ltd
Previous close
₹871.15
Day range
₹866.00 - ₹905.95
Year range
₹726.80 - ₹1,639.00
Market cap
158.36B INR
Avg Volume
881.76K
P/E ratio
8.41
Dividend yield
0.68%
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 12.21B | 13.95% |
Operating expense | 5.22B | 16.26% |
Net income | 4.07B | 5.25% |
Net profit margin | 33.30 | -7.63% |
Earnings per share | 22.70 | 5.29% |
EBITDA | 5.09B | 3.21% |
Effective tax rate | 19.75% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.17B | 109.70% |
Total assets | 86.31B | 24.97% |
Total liabilities | 10.18B | -3.29% |
Total equity | 76.12B | — |
Shares outstanding | 179.12M | — |
Price to book | 2.05 | — |
Return on assets | — | — |
Return on capital | 14.74% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 4.07B | 5.25% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Founded
1981
Headquarters
Website
Employees
4,016
